| Pharmaceutical Information |
| Drug Name |
Biperiden hydrochloride |
| Drug ID |
BADD_D00275 |
| Description |
A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine. |
| Indications and Usage |
For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy. |
| Marketing Status |
approved; investigational |
| ATC Code |
N04AA02 |
| DrugBank ID |
DB00810
|
| KEGG ID |
D02246
|
| MeSH ID |
D001712
|
| PubChem ID |
92151
|
| TTD Drug ID |
D0B4TN
|
| NDC Product Code |
Not Available |
| UNII |
K35N76CUHF
|
| Synonyms |
Biperiden | Biperidene | alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol | Biperiden, 1S-(1 alpha,2 alpha(R*),4 alpha)-Isomer | Biperiden, 1R-(1 alpha,2 alpha(R*),4 alpha)-Isomer | Akineton | Biperiden Hydrochloride | Hydrochloride, Biperiden |
|
| Chemical Information |
| Molecular Formula |
C21H30ClNO |
| CAS Registry Number |
1235-82-1 |
| SMILES |
C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
